Safety and Efficacy Study of the Sorin 3D Annuloplasty Ring For Mitral Repair

NCT ID: NCT00567853

Last Updated: 2015-01-26

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE3

Total Enrollment

278 participants

Study Classification

INTERVENTIONAL

Study Start Date

2007-08-31

Study Completion Date

2013-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to collect data on the effectiveness and clinical outcomes of the MEMO 3D Annuloplasty ring as used for mitral valve repair.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Mitral Valve Regurgitation

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

MEMO 3D ring

All patients in the study will be implanted with the MEMO 3D ring

Group Type OTHER

Implantation of the MEMO 3D Annuloplasty Ring

Intervention Type DEVICE

Implantation of the MEMO 3D Annulopalsty Ring for mitral valve repair.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Implantation of the MEMO 3D Annuloplasty Ring

Implantation of the MEMO 3D Annulopalsty Ring for mitral valve repair.

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* The subject is 18 years old or older
* An annuloplasty ring is indicated for reinforcement of a dysfunctional or diseased native mitral valve according to the current medical practice for valvular repair at each site.
* The subject is able to return for all follow-up evaluations of the study.

Exclusion Criteria

* The subject or subject's legal representative is unwilling to sign the informed consent.
* The subject is or will be participating in another medical device or drug clinical trial.
* The subject is a minor, prisoner, institutionalized, or is unable to give informed consent.
* The subject has a life expectance of less than 1 year.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Sorin Group USA, Inc.

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Clark Hargrove, M.D.

Role: PRINCIPAL_INVESTIGATOR

University of Pennsylvania Presbyterian Medical Center

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Minneapolis Heart Institute

Minneapolis, Minnesota, United States

Site Status

Barnes Jewish Hospital

St Louis, Missouri, United States

Site Status

University of Pennsylvania Presbyterian Hospital

Philadelphia, Pennsylvania, United States

Site Status

The Heart Hospital Baylor Plano

Plano, Texas, United States

Site Status

Foothills Medical Centre

Calgary, Alberta, Canada

Site Status

Queen Elizabeth II Health Sciences Centre

Halifax, Nova Scotia, Canada

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States Canada

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

MEMO3D.Reg

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

MitraClip for Severe TR
NCT02863549 UNKNOWN NA